| abstract |
A synthetic pediatric formula for use in the treatment or prevention of a rotavirus-induced infection in a baby, toddler or child, where the synthetic pediatric formula comprises from 0.001 mg / ml to 20 mg / ml of a human milk oligosaccharide and from 5 mg / la 350 mg / l of a nucleotide, where the oligosaccharide in human milk comprises 0.001 mg / ml to 20 mg / ml of 3'-sialyl-lactose, 6'-sialyl-lactose, sialic acid and combinations thereof or from 0.001 mg / ml to 20 mg / ml lacto-N-neotetraose. |